Albuminuria Testing by Race and Ethnicity among Patients with Hypertension with and without Diabetes

Am J Nephrol. 2019;50(1):48-54. doi: 10.1159/000500706. Epub 2019 Jun 5.

Abstract

Background: Detection of chronic kidney disease (CKD) with urine albumin-to-creatinine ratio (UACR) among patients with hypertension (HTN) provides an opportunity for early treatment, potentially mitigating risk of CKD progression and cardiovascular complications. Differences in UACR testing patterns among racial/ethnic populations at risk for CKD could contribute to known disparities in CKD complications.

Methods: We examined the prevalence of UACR testing among low-income adult primary care patients with HTN, defined by a new administrative code for HTN or 2 clinic blood pressures >140/90 mm Hg between January 1, 2014, and January 1, 2017, in one public health-care delivery system with a high prevalence of end-stage kidney disease among race/ethnic minorities. Logistic regression was used to identify odds of UACR testing within 1 year of a HTN diagnosis, overall, and by racial/ethnic subgroup, adjusted for demographic factors, estimated glomerular filtration rate, and HTN severity. Models were also stratified by diabetes status.

Results: The cohort (n = 16,414) was racially/ethnically diverse (16% White, 21% Black, 34% Asian, 19% Hispanic, and 10% other) and 51% female. Only 35% of patients had UACR testing within 1 year of a HTN diagnosis. Among individuals without diabetes, odds of UACR testing were higher among Asians, Blacks, and Other subgroups compared to Whites (adjusted OR [aOR] 1.19; 95% CI 1.00-1.42 for Blacks; aOR 1.33; 1.13-1.56 for Asians; aOR 1.30; 1.04-1.60 for Other) but were not significantly different between Hispanics and Whites (aOR 1.17; 0.97-1.39). Among individuals with diabetes, only Asians had higher odds of UACR testing compared to Whites (aOR 1.35; 1.12-1.63).

Conclusions: Prevalence of UACR testing among low-income patients with HTN is low in one public health-care delivery system, with higher odds of UACR testing among racial/ethnic minority subgroups compared to Whites without diabetes and similar odds among those with diabetes. If generalizable, less albuminuria testing may not explain higher prevalence of kidney failure in racial/ethnic minorities.

Keywords: Diabetes; Albuminuria testing; Chronic kidney disease; Chronic kidney disease disparities; Hypertension; Racial disparities; Safety-net clinic; Vulnerable populations.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Albuminuria / diagnosis*
  • Albuminuria / etiology
  • Asian People / statistics & numerical data
  • Black or African American / statistics & numerical data
  • Creatine / urine
  • Cross-Sectional Studies
  • Diabetic Nephropathies / complications*
  • Diabetic Nephropathies / urine
  • Female
  • Glomerular Filtration Rate
  • Health Status Disparities
  • Healthcare Disparities / statistics & numerical data*
  • Hispanic or Latino / statistics & numerical data
  • Humans
  • Hypertension / complications*
  • Hypertension / urine
  • Kidney Failure, Chronic / epidemiology
  • Kidney Failure, Chronic / etiology
  • Kidney Failure, Chronic / prevention & control
  • Male
  • Middle Aged
  • Minority Groups / statistics & numerical data*
  • Prevalence
  • Serum Albumin, Human / urine
  • Urinalysis / statistics & numerical data*
  • White People / statistics & numerical data
  • Young Adult

Substances

  • Creatine
  • Serum Albumin, Human